|
[1]
|
Ali Farid, A., El Bambi, M., El Dali, O., et al. (1996) The Menopause Rating Scale (MRS1Ⅱ)-Clusters of Menopausal Symptoms. Maturitas, 27-201.
|
|
[2]
|
赵迪. 积极心理学视角下农村中年女性绝经前期、围绝经期和绝经后期绝经综合征的对比研究[D]: [硕士学位论文]. 济南: 山东大学, 2019.
|
|
[3]
|
周彦吟. 新加坡华人妇女绝经综合征中医证型研究[D]: [博士学位论文]. 广州: 广州中医药大学, 2021.[CrossRef]
|
|
[4]
|
吴卓, 吴佳聪, 万春花. 2000例围绝经期妇女绝经综合征及相关因素分析[J]. 河南预防医学杂志, 2016, 27(7): 485-487+538. [Google Scholar] [CrossRef]
|
|
[5]
|
奚鑫, 冉海龙, 陈诚, 杜倩, 李文军, 徐驰宇, 曾婷婷, 李阳美, 雷迅, 范尧, 刘松青, 俞丽丽. 围绝经期一日门诊多学科健康宣教模式对女性绝经激素治疗认知的影响[J]. 中国药房, 2022, 33(5): 628-634.
|
|
[6]
|
Lobo, R.A. (2017) Hormone-Replacement Therapy: Current Thinking. Nature Reviews Endocrinology, 13, 220-231. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Burger, H.G., MacLennan, A.H., Huang, K.-E. and Castelo-Branco, C. (2012) Evidence-Based Assessment of the Impact of the WHI on Women’s Health. Climacteric, 15, 281-287. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Baber, R.J., Panay, N. and Fenton, A. (2016) 2016 IMSRecommendations on Women’s Midlife Health and Menopause Hormone Therapy. Climacteric, 19, 109-150. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Gambacciani, M., Biglia, N., Cagnacci, A., et al. (2018) Menopause and Hormone Replacement Therapy: The 2017 Recommendations of the Italian Menopause Society. Minerva Ginecologica, 70, 27-34.
|
|
[10]
|
Palacios, S., Stevenson, J.C., Schaudig, K., Lukasiewicz, M. and Graziottin, A. (2019) Hormone Therapy for First-Line Management of Menopausal Symptoms: Practical Recommendations. Women’s Health, 15, Article ID: 1745506519864009. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Rarick, L. (2007) United States Regulatory Considerations for In-trauterine Progestins for Hormone Replacement Therapy. Contraception, 75, S140-S143. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
de Villiers, T.J., Pines, A., Panay, N., Gambacciani, M., Archer, D.F., Baber, R.J., Davis, S.R., Gompel, A.A., Henderson, V.W., Langer, R., Lobo, R.A., Plu-Bureau, G. and Sturdee, D.W. (2013) Updated 2013 International Menopause Society Recommendations on Menopausal Hormone Therapy and Preventive Strategies for Midlife Health. Climacteric, 16, 316-337. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Stute, P., Neulen, J. and Wildt, L. (2016) The Impact of Mi-cronized Progesterone on the Endometrium: A Systematic Review. Climacteric, 19, 316-328. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
The North American Menopause Society (2017) The 2017 Hormone Therapy Position Statement of the North American Menopause Society. Menopause, 24, 728-753. [Google Scholar] [CrossRef]
|
|
[15]
|
Christ, J.P., Gunning, M.N., Palla, G., et al. (2018) Estro-gen Deprivation and Cardiovascular Disease Risk in Primary Ovarian Insufficiency. Fertility and Sterility, 109, 594-600. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Gupte, A.A., Pownall, H.J. and Hamilton, D.J. (2015) Estro-gen: An Emerging Regulator of Insulin Action and Mitochondrial Function. Journal of Diabetes Research, 2015, Article ID: 916585. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Renoux, C., Dell’Aniello, S., Garbe, E. and Suissa, S. (2010) Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke: A Nested Case-Control Study. BMJ, 340, Article No. c2519. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Løkkegaard, E., Nielsen, L.H. and Keiding, N. (2017) Risk of Stroke with Various Types of Menopausal Hormone Therapies: A National Cohort Study. Stroke, 48, 2266-2269. [Google Scholar] [CrossRef]
|
|
[19]
|
Anderson, G.L., Chlebowski, R.T., Rossouw, J.E., et al. (2006) Prior Hormone Therapy and Breast Cancer Risk in the Women's Health Initiative Randomized Trial of Estrogen Plus Progestin. Maturitas, 55, 103-115. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
郁琦, 崔小娟. 绝经激素治疗临床应用争议及展望[J]. 中国计划生育和妇产科, 2022, 14(1): 3-6+28.
|